Back
AbbVie Vs. Vertex Pharmaceuticals Industry Stock Comparison
Sell
40
ABBV
AbbVie
Last Price:
173.36
Seasonality Move:
3.38%
Buy
55
VRTX
Vertex Pharmaceuticals
Last Price:
463.77
Seasonality Move:
10.26%
Sell
40
AbbVie (ABBV)
is a Sell
Is AbbVie a Buy, Sell or Hold?
- The current AbbVie [ABBV] share price is $173.37. The Score for ABBV is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- ABBV is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
55
Vertex Pharmaceuticals (VRTX)
is a Buy
Is Vertex Pharmaceuticals a Buy, Sell or Hold?
- The current Vertex Pharmaceuticals [VRTX] share price is $463.73. The Score for VRTX is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- VRTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ABBV Stock Price Chart
VRTX Stock Price Chart
What is Vertex Pharmaceuticals's stock price today?
-
The Vertex Pharmaceuticals share price today is $463.73
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRTX is experiencing slight buying pressure.
ABBV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.72 | Sell |
| Relative Strength Index (14 RSI): | 38.05 | Sell |
| Chaikin Money Flow: | -1046334 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (168.49 - 182.61) | Sell |
| Bollinger Bands (100): | (179.27 - 198.19) | Sell |
VRTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.39 | Sell |
| Relative Strength Index (14 RSI): | 46.87 | Sell |
| Chaikin Money Flow: | 142512 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (452.97 - 485.41) | Sell |
| Bollinger Bands (100): | (461.47 - 489.17) | Sell |
ABBV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 175.25 | Sell |
| 20-day SMA: | 175.19 | Sell |
| 50-day SMA: | 184.96 | Sell |
| 200-day SMA: | 178.92 | Sell |
| 8-day EMA: | 175.26 | Sell |
| 20-day EMA: | 177.49 | Sell |
| 50-day EMA: | 182.23 | Sell |
| 200-day EMA: | 178.46 | Sell |
VRTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 465.67 | Sell |
| 20-day SMA: | 462.14 | Buy |
| 50-day SMA: | 472.45 | Sell |
| 200-day SMA: | 456.84 | Buy |
| 8-day EMA: | 465.44 | Sell |
| 20-day EMA: | 466.94 | Sell |
| 50-day EMA: | 470.6 | Sell |
| 200-day EMA: | 454.26 | Buy |
AbbVie Earnings Growth & ABBV Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.19 per share, and an increase next year of $1.23 per share.
Vertex Pharmaceuticals Earnings Growth & VRTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.74 per share, a decrease next quarter of $0.00 per share, a decrease this year of $14.53 per share, and an increase next year of $18.25 per share.
AbbVie Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Vertex Pharmaceuticals Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||